Status:
RECRUITING
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
Chronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a...
Detailed Description
This study is designed as an investigator-initiated, multi-center, prospective and observational real world study based on mainland Chinese population. The investigators aimed to investigate the occur...
Eligibility Criteria
Inclusion
- Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition;
- Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD;
- Healthy population.
- Signed the informed consent voluntarily.
Exclusion
- 。Patients identified to be unsuitable for enrollment by the study physician.
Key Trial Info
Start Date :
December 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 27 2028
Estimated Enrollment :
90000 Patients enrolled
Trial Details
Trial ID
NCT05188885
Start Date
December 27 2021
End Date
December 27 2028
Last Update
November 4 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second People's Hospital of Nanhai District in Foshan City
Foshan, Guangdong, China
2
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, China
3
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
4
Wuhua County People's Hospital
Meizhou, Guangdong, China